Gion, M., García-Mosquera, J., Pérez-García, J., Peg, V., Ruiz-Borrego, M., Stradella, A., . . . Cortés, J. (2024). Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab. SPRINGER.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Gion, M., et al. Correlation Between Trophoblast Cell-surface Antigen-2 (Trop-2) Expression and Pathological Complete Response in Patients with HER2-positive Early Breast Cancer Treated with Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab. SPRINGER, 2024.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Gion, M., et al. Correlation Between Trophoblast Cell-surface Antigen-2 (Trop-2) Expression and Pathological Complete Response in Patients with HER2-positive Early Breast Cancer Treated with Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab. SPRINGER, 2024.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.